Cooperation AgreementCooperation Agreement • August 19th, 2022 • Catalyst Biosciences, Inc. • Pharmaceutical preparations • Delaware
This Cooperation Agreement (this “Agreement”) is made and entered into as of August 18, 2022 (the “Effective Date”) by and among Catalyst Biosciences, Inc., a Delaware corporation (the “Company”), and each of the parties listed on Exhibit A hereto (each, an “Investor” and collectively, the “Investors” or, with their respective controlled Affiliates, except as noted on Exhibit A, the “Investor Group”). The Company and each of the Investors are each herein referred to as a “party” and collectively, the “parties.”)
